Melissa B. Epperly
Independent DirectorMs. Melissa B. Epperly, MBA, is Chief Financial Officer of Tenpoint Therapeutics Limited. She is Independent Director at Roivant Sciences Ltd. from June 29, 2022. She has been Independent Director of Nautilus Biotechnology, Inc. since June 9, 2021. She served as Independent Director of Kinnate Biopharma Inc. from October 2020 to April 3, 2024. Ms. Epperly served as the Chief Financial Officer and Treasurer at Zentalis Pharmaceuticals, Inc. since September 2019 until April 05, 2024. She served on the Legacy Nautilus board of directors from January 2021 to June 9, 2021. Ms. Epperly was the Chief Financial Officer at PsiOxus Therapeutics Ltd from June 2018 to August 2019. Ms. Epperly was a Vice President and Head of GS SUSTAIN Americas at Goldman Sachs Group Inc. in equity research in New York and London, Research Division from November 2007 to July 2012. Ms. Epperly served as Chief Financial Officer and Head of Business Development at R-Pharm US from October 2015 to June 2018, where she led the company financial operations and business development. From August 2012 to September 2015, Ms. Epperly served as a Director at Anchorage Capital Group, a credit-focused hedge fund. She joined the GS SUSTAIN research team in November 2007. Ms. Epperly was a Management Consultant with Bain & Company and focused on healthcare and private equity. She previously worked at Morgan Stanley in healthcare investment banking and banking management. Ms. Epperly has an MBA from Harvard Business School and a BA in Biochemistry and Economics from the University of Virginia. Ms. Epperly serves as Chief Financial Officer of Zeno Pharma, LLC.
Positions
- Company NameRoivant Sciences Ltd.Stock CodeROIVPositionIndependent DirectorColleagues
- MGMatthew GlineCEO & Director
- IOIlan OrenIndependent Chairman
- EVEric VenkerPresident & CEO of Immunovant
- MSMayukh SukhatmePresident, Chief Investment Officer & Director
- FMFrank M. TortiPresident & Vant Chair
- RPRichard PulikChief Financial Officer
- DADaniel A. GoldIndependent Director
- MBMelissa B. EpperlyIndependent Director
- Company NameNautilus Biotechnology, Inc.Stock CodeNAUTPositionIndependent DirectorColleagues
- SMSujal M. PatelCo-Founder, CEO, President, Secretary & Director
- MLMatthew L. PosardIndependent Chairman of the Board
- PMParag MallickCo-Founder, Chief Scientist & Director
- AMAnna MowryCFO & Treasurer
- MBMatthew B. MurphyGeneral Counsel
- AFAmber FaustVice President of Global Sales
- MMMatthew McIlwainIndependent Director
